|
|
Transplantation-Heart/Heart Lung
|
|
|
Mechanical circulatory support guidelines set
The International Society of Heart and Lung Transplantation issued the first comprehensive guidelines for all phases dealing with patients who receive left ventricular assist devices or related equipment. "Because the number of treated patients has increased, and because patients now live... »
LVADs for Severe Heart Failure Gradually Take Hold
A sea change in management of severe heart failure began two and a half years ago, in January 2010, when the Food and Drug Administration approved U.S. marketing of the HeartMate II continuous-flow, left ventricular assist device for destination therapy. Patients, cardiologists, and cardiothoracic... » SAN FRANCISCO -- Thanks to a large study that identifies significant risk factors for death following implantation of a left ventricular assist device (LVAD) as destination therapy, doctors can better identify candidates whose expect 1- and 2-year survival rates with LVAD therapy approach... » FT. LAUDERDALE, FLA. – Left ventricular assist devices are associated with a significant survival advantage compared with other mechanical support modalities implemented before heart transplant, as shown in an analysis of more than 13,000 patients.
There are a variety of support strategies... » Point: Take Patients Off as Soon as Possible
Given current evidence, it is extreme and premature to take all patients off corticosteroids within 3 months of heart transplantation.
Steroids have been used since the beginning of heart transplant therapy, and are still among our most useful drugs... »
LVAD Support Nears Transplant Survival for Some
LVAD Support Optimal During Bridge to Transplant
Is Early Discontinuation of Corticosteroids Warranted in All Heart Transplant Recipients?
| Jun 26 - 29 Coeur d'Alene, ID | Western Thoracic Surgical Association (WTSA): Annual Meeting |
| Jun 27 - 29 Frankfurt, | Congenital and Structural Interventions (CSI 2013) |
| Oct 31 - Nov 2 Chicago, IL | American Society for Radiation Oncology (ASTRO): Chicago Multidisciplinary Symposium in Thoracic Oncology |